scispace - formally typeset
M

Morgan E. Grams

Researcher at Johns Hopkins University

Publications -  373
Citations -  18876

Morgan E. Grams is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 61, co-authored 281 publications receiving 12773 citations. Previous affiliations of Morgan E. Grams include Columbia University & University of Michigan.

Papers
More filters
Journal ArticleDOI

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

Jeffrey D. Stanaway, +1053 more
- 10 Nov 2018 - 
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.
Journal ArticleDOI

Chronic Kidney Disease Diagnosis and Management: A Review

TL;DR: Optimal management of CKD includes cardiovascular risk reduction, treatment of albuminuria, avoidance of potential nephrotoxins, and adjustments to drug dosing (eg, many antibiotics and oral hypoglycemic agents).
Journal ArticleDOI

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

TL;DR: Proton pump inhibitor use was associated with incident CKD in unadjusted analysis and in analysis adjusted for demographic, socioeconomic, and clinical variables and future research should evaluate whether limiting PPI use reduces the incidence of CKD.
Journal ArticleDOI

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

TL;DR: Kidney failure risk equations developed in a Canadian population showed high discrimination and adequate calibration when validated in 31 multinational cohorts, but the original risk equations overestimated risk in some non-North American cohorts.